Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-08

Clinical Trial Update: Long-term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports long-term safety and efficacy data for itopride hydrochloride in patients with functional dyspepsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Itopride hydrochloride (itopride hydrochloride)

Snippet

Sponsor: Forest Laboratories | Conditions: Dyspepsia | Phase 3 | Status: COMPLETED